section name header

Evidence summaries

Endoscopic Retrograde Cholangiopancreaticography (Ercp) with or Without Stenting in Patients with Pancreaticobiliary Malignancy, Prior to Surgery

Endoscopic biliary stenting may not reduce mortality in patients with pancreatico-biliary malignancy. Level of evidence: "C"

A Cochrane review [Abstract] 1 included 2 studies with a total of 125 subjects. 62 patients undergoing pancreatico-duodenectomy underwent ERCP with biliary stenting and 63 had ERCP without biliary stenting prior to surgery. Pre-surgical mortality was not significantly affected by stenting (OR 3.14, 95% CI 0.12 to 79.26), while there were significantly more complications in the stented group (OR 43.75, 95% CI 2.51 to 761.8). Stenting had no significant effect on the post-surgical mortality (OR 0.75, 95% CI 0.25 to 2.24). However, post-surgical complications were significantly less in the stented group (OR 0.45, 95% CI 0.22 to 0.91). Overall mortality (OR 0.81, 95% CI 0.17 to 3.89) and complications (OR 0.50, 95% CI 0.01 to 23.68) were not significantly different in the two groups.

Comment: The quality of evidence is downgraded by imprecise results (few patients and wide confidence intervals) and by study quality (inadequate or unclear allocation concealment).

    References

    • Mumtaz K, Hamid S, Jafri W. Endoscopic retrograde cholangiopancreaticography with or without stenting in patients with pancreaticobiliary malignancy, prior to surgery. Cochrane Database Syst Rev 2007 Jul 18;(3):CD006001. [PubMed]

Primary/Secondary Keywords